Ares Capital Fell Enough to Push Its Yield Near 10%. Here's the Number That Actually Worries Me.

Ares Capital added 4 more loans to non-accrual in Q2, lifting its non-accrual rate to 2.4% of investments at amortized cost (from 2.1%), though it remains below the company’s historical ~3% average. Shares are down ~10% from the 52-week high ($22.51) to about $20, pushing the dividend yield to ~9.6% (near 10%), while core earnings are softer ($0.94/share vs $1.00 a year ago) and rely on net realized gains and carryover taxable spillover income ($1.38/share). The article is cautious: non-accruals rising is a risk to dividend coverage, but not yet a decisive red flag given diversification and a >$1B long-run record of realized gains.

Analysis

In BDCs, the first reaction to rising non-accruals is usually too binary: the market either ignores it as noise or prices in an imminent dividend cut. The more durable mechanism is slower—each incremental credit issue narrows the cushion between recurring interest income and the payout, which eventually forces the stock to trade less like a bond proxy and more like a cyclical lender. ARCC’s scale and diversification should let it absorb isolated problem loans better than smaller, more concentrated peers such as CSWC, and any sector stress may actually widen the quality gap in ARCC’s favor.

The key catalyst path over the next 1-3 quarters is not the current headline rate, but whether funding costs stay elevated while portfolio yields reset more slowly. If that spread stays tight, core earnings can remain under pressure even without a blow-up in defaults, meaning realized gains and spillover income become a bridge rather than a repeatable dividend engine. Over 6-18 months, a mild credit normalization would likely compress multiples across the BDC group, with the weakest balance sheets and least diversified portfolios repricing first.

Contrarian view: the market is probably overfocused on the 9-10% yield and underfocused on how quickly “best-in-class” can still de-rate if credit conditions revert toward normal. This is not an immediate distress story, but it is a slow-burn multiple risk. The constructive case breaks if non-accruals move above the long-run norm or if core earnings miss the dividend for multiple quarters without offsetting realized gains.

Key Decisions for Investors

• No immediate short in ARCC; treat this as a monitor item and wait for the next quarterly update. Falsifier: non-accruals above the historical norm or another quarter of dividend coverage erosion.
• Relative-value idea: long ARCC / short CSWC on any broad BDC selloff. Thesis is that ARCC’s diversification and realization track record should outperform if credit stress broadens over 1-3 quarters; stop if ARCC’s credit metrics deteriorate toward peer levels.
• For income mandates, only add ARCC on pullbacks where the yield approaches or exceeds 10% and next-quarter core EPS appears stable. Risk/reward is decent, but only if the dividend remains covered by recurring earnings plus modest spillover.
• Set an alert on the BDC sector if financing spreads widen further or if banks tighten lending standards. That would be the cleaner signal to reduce exposure to higher-beta BDCs before NAV pressure becomes visible.